fbpx
QQQ
+ 2.19
278.28
+ 0.78%
DIA
-2.30
279.39
-0.83%
SPY
-1.15
340.63
-0.34%
TLT
+ 1.07
158.41
+ 0.67%
GLD
+ 0.53
178.00
+ 0.3%

Microdose Presents Psychedelic Capital: A Virtual Investment Conference Highlighting Prominent Industry Players

September 30, 2020 10:37 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

Cannabis and psychedelic investors alike are paying close attention to the burgeoning psychedelic space.  Due to widespread demand, Microdose Psychedelic Insights and the The Conscious Fund have aligned once again to host Psychedelic Capital, a monthly conference covering the emerging psychedelic markets.

September’s edition will consist of lively sponsor exhibitions, such as Doug Dryslade, the newly appointed CEO of Cybin Corp., Dr. Jeffrey Becker and Gregg Peterson of Bexson Biomedical, Dr. Joseph Tucker, CEO from MagicMed Industries, as well as Audia Barnett, COO of Wake Jamaica, along with Olga Chernoloz, Chief Scientific Officer of Wake Network. In addition to sponsor presentations by these luminaries, the event will also feature dynamic speakers (listed below) from across the psychedelic industry as well. 

Speaker highlights from the September event include: 

  • “Technodelic” videogame designer, Robin Arnott
  • Joël Brierre, founder of Kaivalya Kollectiv
  • Danilo Tomanovic, president of ML Deep Dive, 
  • Ronan Levy, executive chairman of Field Trip Health, 
  • International women’s rights activist Lynsey Bourke
  • Nikolai Vassev, founder of Mindleap Health
  • Tom Galea, director and cofounder of Lumenate.
  • Dr. Erica Zelfand, Founder of Simba Health

The conference features 20 minute presentations followed by an engaging 10 minute Q&A session where you can interact as an audience with panelists from across the psychedelic spectrum. With experts and thought leaders hailing from the top companies in the space, you can be sure to enjoy deep insights and commentary at the cutting edge of the psychedelic renaissance


Related Articles

Little Dragon's Yukimi Nagano On Psychedelics, Isolation And Connection

One would think that, in the midst of a global pandemic where most of us are living in a state of forced isolation, a sense of dread and impending doom may cloud our everyday lives and interactions. Pessimism and hopelessness abound, and it gets harder and harder to stay positive. read more

4 Lessons The Emerging Psychedelics Industry Can Learn from The Cannabis Boom

By Evan Nison, NisonCo PR. read more

Business Insights From Curaleaf's Boris Jordan: 'Go With Your First Instinct'

"Once you start to over-analyze stuff, you do mess it up," Boris Jordan, the Executive Chairman of Curaleaf Holdings Inc. (OTCQX: CURLF) and Chief Investment Officer at Measure8, told Benzinga's Jason Raznick. read more